Skip to main contentSkip to footer content
Back to all entries

tiakis Biotech AG has partnered with Northway Biotech to scale up its production capabilities.

tiakis Biotech AG (formerly Proteo Biotech AG) has announced that the Company has partnered with a new CMO Northway Biotech in Vilnius, Lithuania (https://www.northwaybiotech.com) to commence a tech transfer of its innovative Tiprelestat production processes.

The Company is highly confident that this will open the door to a further expansion of its clinical development programs and to anticipate future demands for its investigational medical product Tiprelestat.

Ramp-up of the production capabilities is expected to be completed in Q4 2022.

Contact

tiakis BIOTECH AG
Sophienblatt 40
24103 Kiel
Germany
phone: +49 431 8888-462
fax: +49 431 8888-463
email: info@tiakis.bio